Global /China /Healthcare /Medical Distribution /688366
chevron_leftBack
Shanghai Haohai Biological Technology Co., Ltd. logo

Shanghai Haohai Biological Technology Co., Ltd.

688366
SSE: 688366 Delayed
39.65CNY -0.1%
5.85 USD
As of 7 June 2026, Shanghai Haohai Biological Technology Co., Ltd. has a market cap of $1.22B USD, ranking #9608 globally and #2612 in China. It ranks #837 in the Healthcare sector, and #28 in the Medical Distribution industry.
Global Rank
9608
Country Rank
2612
Sector Rank
837
Industry Rank
28
Key Stats
Market Cap
$1.22BUSD
8.24B CNY
Enterprise Value
$947.89MUSD
6.42B CNY
Revenue (TTM)
$354.41MUSD
2.4B CNY
Net Income (TTM)
$34.6MUSD
234.26M CNY
Profit Margin
9.8%
PE Ratio
35.2
PS Ratio
3.4
PB Ratio
1.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Jianying Wu open_in_new
Employees
2,110
Founded
2007
Website
3healthcare.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.1% 1.4% 1% -14% -22% -24%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
688366
上海昊海生物科技股份有限公司 Class A
ISIN: CNE100003NX4
Shares Out.:
190.204M1 Shares Float: 50.5M2
TV:
SA:
YF:
GF:
BA:
MS:
39.65 CNY
Frankfurt Stock Exchange
MIC: XFRA
5HB
上海昊海生物科技股份有限公司 Shs -H- Unitary 144A/Reg S
ISIN: CNE100001W69
Shares Out.:
35.348M1 Shares Float: 35.313M2
TV:
SA:
YF:
GF:
BA:
5HB
MS:
2.40 EUR
Hong Kong Stock Exchange
MIC: XHKG
6826
上海昊海生物科技股份有限公司 Shs -H- Unitary 144A/Reg S
ISIN: CNE100001W69
Shares Out.:
35.348M1 Shares Float: 35.313M2
TV:
SA:
YF:
GF:
BA:
MS:
22.12 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequency, and ultrasonic instruments. It also engages in the research and development of biological engineering and pharmaceutical products and related technology transfer activities, consulting, and other services; research, development, production, and sales of radio frequency instruments; cell technology and biochemical product technology research and development; computer, communication, and other electronic equipment manufacturing; instrument manufacturing; manufacture and sale of biological reagents, biological agents, and biological materials; medical-grade sodium hyaluronate bio-based skincare products; intraocular lens and related products; intraocular lens injectors and materials, equipment, chemical products, and accessories for contact lenses and artificial lenses; sale of ophthalmology products; and provision of other machines and accessories. In addition, the company is involved in property management; business management consulting; non-residential real estate leasing; provision of technical services, technology promotion, development and transfer, technical consulting and exchange; wholesale of cosmetics; import and export of goods; import and export of technology; and information technology consulting services. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. The company was founded in 2007 and is headquartered in Shanghai, China.

Similar Companies

Industry: Medical Distribution (China)
Name
Market Cap diff.
PE
$7.48B
58.61B HKD
514%
7.2
$3.82B
25.88B CNY
214%
13.3
$1.63B
11.06B CNY
34%
31.2
$1.24B
8.37B CNY
1.5%
-
$1.23B
8.31B CNY
0.8%
17.9
$1.05B
7.12B CNY
-14%
12.8
Industry: Medical Distribution (Global)
Name
Market Cap diff.
PE
MCK
$100.76B
8K%
24.0
COR
$60.58B
5K%
37.4
$47.73B
4K%
29.6
HSIC
$8.47B
595%
22.6
GALE
$5.32B
4.2B CHF
337%
23.0
DKSH
$4.85B
3.83B CHF
298%
18.9
chevron_leftBack